Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
CSE Real-Time Last Sale USD
Today's Change
Price Quote as of

Today's Trading

Day Low 2.740
Day High 2.870
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Acreage Holdings Inc is a vertically integrated, multi-state operator in the cannabis industry. Its business operations include cultivating, processing, distributing and retailing cannabis. The Company derives its revenues from its retail dispensary business where cannabis and cannabis-infused products are sold to consumers. Its geographic segments include New England, Mid-Atlantic, Midwest, West and South.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Latest Press Releases

Canopy Growth & Acreage Holdings Agree to Modify Plan of Arrangement as Canopy Growth's U.S. Expansion Continues
- PR Newswire - PRF - Thu Jun 25, 6:00AM CDT
PR Newswire - PRF - CMTX
Thu Jun 25, 6:00AM CDT
Canopy Growth and Acreage agree to amend plan of arrangement to provide potential additional upside for all shareholders Amended arrangement provides for up-front cash payment to Acreage shareholders and certain convertible security holders in the aggregate amount of Amended arrangement creates two classes of Acreage shares, including a new floating share that provides upside opportunity for Acreage shareholders that is not tied to fixed exchange ratioProvides capital for Hemp operations, allowing Acreage to participate in the burgeoning CBD market and , /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NYSE: CGC) and Acreage Holdings, Inc. ("Acreage") (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0VZ), today announced they have entered into an agreement (the "New Agreement") to amend the terms of the arrangement agreement dated , as amended on , between Canopy Growth and Acreage (the "Arrangement Agreement"). Pursuant to the Arrangement Agreement, Canopy Growth agreed to acquire all of the issued and outstanding securities of Acreage pursuant to a plan of arrangement under the () (the "Plan of Arrangement"), contingent upon the occurrence of changes in U.S. federal law to permit the general cultivation, distribution, and possession of marijuana (the "Triggering Event") and subject to the satisfaction or waiver of certain conditions to closing as set out in the Arrangement Agreement.
Psychedelics Seek to Emulate Cannabis' Medical Legalization Model
- PR Newswire - PRF - Thu Jun 4, 8:00AM CDT
PR Newswire - PRF - CMTX
Thu Jun 4, 8:00AM CDT
, /PRNewswire/ -- According to data provided by the World Health Organization (), depression is a common illness worldwide, with an estimated 264 million people affected. Depression is different from usual mood fluctuations and short-lived emotional responses to challenges in everyday life. Especially when long-lasting and with moderate or severe intensity, depression may become a serious health condition. In recent years, studies have shown that psychedelic therapy might be the answer. Dr , Head of the Centre for Psychedelic Research at Imperial College, , which opened in , explained in article by that "most conventional drugs come with a bunch of side effects and if they work, they often do so through muting a person's emotional range. Psychedelic therapy brings multiple advantages: it can work after just one or two sessions (unlike psychotherapy or standard drugs, which can take weeks or months to work) with minimal toxicity and people can remain well long after the drug has left their bodies, sometimes entirely transforming their sense of well-being and life satisfaction." Newleaf Brands Inc. (OTC: NLBIF) (CSE: NLB), Planet 13 Holdings Inc. (OTC: PLNHF), Pyxus International, Inc. (NYSE: PYX), New Age Beverages Corporation (NASDAQ: NBEV), Acreage Holdings Inc. (OTC: ACRGF) (CSE: ACRG.U)
Shifting Attitudes Towards Mental Health Open Doors to Innovative New Therapies
- PR Newswire - Wed Apr 29, 8:00AM CDT
PR Newswire - CMTX
Wed Apr 29, 8:00AM CDT
Newly developed cannabis products, both for medical and adult-use purposes, were at the forefront of the societal and behavioral shift towards more widespread acceptance of an industry previously damaged by stigmas. This young industry made some impressive strides in recent years; according to data provided by BDSA and ArcView Market Research, legal cannabis sales grew by 46% to USD 14.7 Billion in 2019, a significant increase from the 16% growth of 2018 and the industry's highest annual rate of growth to-date. BDSA projects that U.S. legal cannabis sales will approach USD 34 Billion by 2025, increasing at an 18% CAGR. This growth is largely attributed to the markets of Canada, California and Massachusetts, which were the largest contributors to global sales growth in 2019, supplemented by the expanding medical markets of Florida and Oklahoma. "By relaxing product restrictions and adopting more of a free-market approach to licensing, states like Florida are realizing the potential of medical cannabis sales," said Roy Bingham, Co-Founder and CEO at BDSA. "In addition, light regulation and low tax rates in states like Oklahoma enable citizen access, greater performance over the illicit markets and a healthy tax revenue stream for the state." Now, a new field of potential medicinal substances, psychedelics, may follow the path of the cannabis industry. Global Trac Solutions Inc. (OTC: PSYC), Cresco Labs Inc. (OTC: CRLBF) (CSE: CL), 22nd Century Group, Inc. (NYSE: XXII), Acreage Holdings Inc. (OTC: ACRGF) (CSE: ACRG.U), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB)
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.590 +6.95% increase
on 08/25/20
Period Open:2.720
Price movement based on the high, low and last over the given period.
2.990 -7.36% decrease
on 08/31/20
+0.050 (+1.84%) increase
since 08/21/20
3-Month 2.020 +37.13% increase
on 07/17/20
Period Open:2.470
Price movement based on the high, low and last over the given period.
3.250 -14.77% decrease
on 08/10/20
+0.300 (+12.15%) increase
since 06/22/20
52-Week 1.490 +85.91% increase
on 03/19/20
Period Open:8.590
Price movement based on the high, low and last over the given period.
9.110 -69.59% decrease
on 09/23/19
-5.820 (-67.75%) decrease
since 09/20/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies